have evolved ways to evade host immune responses by modulating HLA expression and/or 54 processing. Here, we provide evidence that aberrant RNA products of influenza virus genome 55 replication can trigger RIG-I/MAVS-dependent remodeling of the cell surface, increasing 56 surface presentation of HLA proteins known to inhibit the activation of an immune cell known as 57 a natural killer (NK) cell. While this HLA upregulation would seem to be advantageous to the 58 virus, it is kept in check by the viral non-structural 1 (NS1) protein, which limits RIG-I 59 activation and interferon production by the infected cell. 60 INTRODUCTION 4 17). NK cells, whose function is regulated by an array of activating and inhibitory receptors, 91 have an important role in the control of IAV infection in mice (18, 19) . The activating NKp44 92 and NKp46, as well as co-stimulatory 2B4 and NTB-4 receptors aid in recognition and killing of 93 IAV-infected cells by binding hemagglutinin (HA) protein on their surface (20) (21) (22) . In mice, 94
NKp46-deficiency results in increased morbidity and mortality following IAV infection, 95 demonstrating the importance of this NK cell receptor in the control of infection (23, 24) . 96
Because binding of NKp46 to viral HA protein is dependent on sialylation of the O-glycosylated 97 residues of NKp46, IAV can counter this recognition by cleaving the receptor sialic acids using 98 the viral neuraminidase (NA) (25, 26) . IAV can also circumvent NK cell-mediated antiviral 99 responses by increasing the expression of inhibitory ligands, such as the class I human leukocyte 100 antigen (HLA), also known as the human class I major histocompatibility complex (class I 101 MHC), on the surface of infected cells. Class I HLA molecules are recognized by the human 102 killer-cell immunoglobulin-like receptors (KIRs) on NK cells (27) . Increased binding of 103 inhibitory KIRs to class I HLA proteins on IAV-infected cells have been shown to inhibit NK 104 cell function (28) . Previously, we demonstrated that IAV infection in mice is associated with 105 increased expression of mouse class I MHC on lung epithelial cells (29). On mouse NK cells the 106 functional analogues of KIRs are inhibitory Ly49 receptors; we observed that disruption of 107 inhibitory Ly49:class I MHC interactions improved survival of IAV-infected mice. Our study 108 demonstrated that upregulation of class I MHC helps IAV evade NK cell-mediated immune 109 responses, but the mechanism by which class I MHC is upregulated during IAV infection is not 110 fully understood. 111 NK cell receptors bind to cognate ligands on the surface of infected cells and integrate 112 activating and inhibitory signals that dictate the extent of NK cell activation (30) . Knowing this, 113
we initiated the current study to better understand how IAV infection affects the expression of 114 ligands for NK cell receptors on the surface of infected epithelial cells. In-depth bioinformatic 115 analysis of publicly available gene expression datasets revealed that IAV infection modulates the 116 expression of a wide array of NK cell ligands, most notably, class I HLA genes that were 117 consistently upregulated across many in vitro infection studies that employed different IAV 118 strains and epithelial cell models. We complemented these findings using an A549 lung 119 epithelial cell infection model. We observed significantly increased presentation of class I HLA 120
and non-classical HLA-E on A/Fort Monmouth/1/1947 (H1N1) IAV-infected A549 cells. HLA 121 5 upregulation was dependent on post-entry steps in replication because UV-inactivated virus had 122 no effect. Specifically, we showed that IAV mvRNAs and DI RNAs are sufficient to increase 123 HLA expression in the absence of infection. MAVS was required for HLA upregulation in 124 response to IAV infection or ectopic mvRNA/DI RNA expression. IAV infection or ectopic 125 mvRNA/DI RNA-expression stimulated production of IFN- and IFN-, and conditioned media 126 from these cells elicited modest increases in HLA presentation from naïve epithelial cells. Using 127 the Janus kinase inhibitor Ruxolitinib (Rux) we demonstrated that signaling downstream of IFN 128 receptors through Jak1 plays a major role in HLA upregulation triggered by IAV replication 129
intermediates. Finally, we determined that IAV NS1 limits cell-intrinsic and paracrine 130 mechanisms of HLA upregulation. Our data indicates that aberrant IAV mvRNAs and DI RNAs 131 stimulate HLA presentation, which may aid viral evasion of immune surveillance. 132
133

RESULTS 134
Influenza A virus infection alters cell surface expression of ligands for NK cell receptors. 135 NK cells control immune responses to IAV infection in vivo (18). NK cell receptors bind 136
to cognate ligands on the surface of infected cells and integrate activating and inhibitory signals 137 that dictate the extent of NK cell engagement (30). We performed an in-depth bioinformatic 138 analysis of publicly available gene expression datasets (Table S1 ) to better understand how 139 expression of known NK cell ligands is modulated by IAV infection in vitro. By focusing on 140 datasets from in vitro IAV infections of standard epithelial cell models including primary human 141 lung epithelial cells and alveolar adenocarcinoma A549 cells, we learned that expression of most 142 known ligands for NK cell receptors is altered during IAV infection ( Fig. 1A) . In particular, 143 there was a consistent trend of upregulation of HLA transcripts in multiple epithelial cell lines in 144 response to infection by diverse IAV strains. These included the HLA-A, -B, -C, and -E proteins 145 that present peptides to immune cells and bind inhibitory receptors on NK cells, as well as HLA-146 F, which binds to KIR receptors with context-dependent activating and inhibitory properties. 147
To confirm reports of NK cell ligand modulation, we infected A549 cells with the 148 A/Puerto Rico/8/1934 strain (PR8) at a MOI=1 for 16 h, at which point RNA was harvested and 149 analyzed by RT-qPCR, which revealed statistically significant increases in HLA-C and 150 significant decreases in MICA, MICB, NECTIN3, CADM1, CDH1, CDH2 and PCNA in PR8-151 6 infected A549 cells ( Fig. 1B) . By contrast, infection of A549 cells with the mouse-adapted 152 A/Fort Monmouth/1/1947 (FM-MA) strain that we previously utilized to study NK cell 153 responses to IAV infection in mice (29), caused significant increases in steady-state mRNA 154 levels of HLA-A, -B, and -C, without causing statistically significant decreases in other NK cell 155
ligands. 156
To determine whether changes in NK cell ligand mRNA levels led to corresponding 157 changes in surface presentation of proteins, we infected A549 cells with PR8 or FM-MA and 158 analyzed cell surface expression of NK cell ligands by flow cytometry (Fig. 2 ). We observed 159 significant upregulation of HLA-A/B/C on the surface of PR8 and FM-MA infected cells ( the expression of NK cell ligands, and that the most striking and consistent finding is increased 172 surface presentation of class I HLA proteins, in agreement with previous studies (28, 29). 173
Defective vRNAs increase surface HLA presentation in a MAVS-dependent manner 174
To determine whether HLA upregulation was a consequence of IAV entry or later steps 175 in viral replication we infected A549 cells with UV-inactivated or control FM-MA virus and 176 measured cell surface HLA levels by flow cytometry using a pan-HLA-A/B/C antibody or an 177 HLA-B-specific antibody. UV treatment damages viral RNA and prevents transcription and 178 replication of the viral genome (31). We observed that, unlike infectious virus that increased cell 179 surface HLA as expected, UV-inactivated inoculum had no effect (Fig. 3A ). 180 7 During replication the IAV RdRp frequently generates defective RNA products including 181 DI RNAs (12) and smaller mvRNAs (14). Like intact full-length vRNAs, DI RNAs bind to the 182 viral nucleoprotein (NP) and assemble into viral ribonucleoprotein (vRNP) structures that limit 183 RIG-I binding (13) . By contrast, mvRNAs do not bind to NP and are thought to be primary RIG-184 I agonists (14). One consequence of IFN signal transduction is increased cell surface HLA 185 presentation (32). Because UV-inactivated IAV was unable to increase HLA surface 186 presentation, we reasoned that increased HLA gene expression could be triggered by innate 
Defective IAV RNAs elicit cell-intrinsic and paracrine upregulation of class I HLA proteins 236
Because signaling downstream of type I IFN receptors increases class I HLA expression 237 (32), we investigated the contribution of soluble factors to HLA expression in IAV infected cells. 238
We infected A549 cells with FM-MA for 17 h and collected cell supernatants, which were UV-239 treated to inactivate virions prior to incubation with naïve A549 cells for an additional 17 h. 240
Donor and recipient A549 cells were stained with anti-HLA-A/B/C or anti-HLA-B antiserum 241 9 and analyzed by flow cytometry. We observed marked increases in surface class I HLA proteins 242 on IAV-infected A549 cells as before, compared to moderate increases on cells incubated with 243
UV-treated conditioned medium (Figs. 5A and B). Staining cells with anti-IAV antiserum 244
confirmed that the UV-treatment of culture supernatants inactivated virions and prevented 245 subsequent infection of naïve A549 cells, mitigating concerns of residual infection in these 246 experiments ( Fig. 5B ). Incubating naïve A549 cells with culture supernatants collected from cells 247 expressing IAV mvRNAs yielded a similar result, with strong significant increases in class I 248 HLA protein levels on the donor cells compared to relatively modest increases on the cells that 249 received the conditioned medium ( Fig. 5C ). Together, these findings indicate that class I HLA 250
can indeed be upregulated on epithelial cells in a paracrine manner in response to infection, but 251 this effect is weaker than the cell-intrinsic class I HLA upregulation on the infected cell. 252
HLA upregulation in response to defective IAV RNAs is dependent on IFN signaling 253
IAV infection induces production of type I and type III IFN proteins by the infected cell 254 that orchestrate autocrine and paracrine anti-viral responses (1, 5) . with the Jak1 inhibitor Rux. In A549 cells transfected with mvRNA-expressing minireplicon, we 270 observed that upregulation of HLA-A/B/C on the cell surface was inhibited by Rux treatment 271 10 ( Fig. 6D ). In control pUC19-transfected cells, Rux had no effect on HLA levels. Together, these 272 data clearly indicate that signaling downstream of IFN receptors through Jak1 plays a major role 273 in HLA upregulation triggered by IAV replication intermediates. 274
NS1 protein limits cell-intrinsic and paracrine upregulation of class I HLA proteins 275
In many experiments FM-MA infections elicited larger increases in class I HLA levels 276 compared to PR8 infections. IAV genome segment 8 encodes the primary innate immune 277 antagonist protein, non-structural protein 1 (NS1), which is highly variable between strains. The 278 FM-MA NS1 protein lacks the carboxy-terminal 28 amino acids found in PR8 NS1 (Fig. 7A ). To 279 assess the role of NS1 in HLA upregulation, we infected A549 cells with FM-MA and PR8, as 280 well as a panel of PR8 viruses with NS1 mutations that compromise its ability to suppress innate 281 immune responses. These include point mutations in NS1 that disrupt its ability to suppress RIG-282 I activation (R38A, K41A or E96A, E97A) (40, 41) and a larger deletion that removes the 283 effector domain and disordered carboxy-terminal tail (N80) (42). Consistent with known 284 properties of NS1 in suppressing IFN production, all three NS1-mutant viruses caused HLA 285 upregulation, and this upregulation was higher than the parental PR8 strain or the FM-MA strain 286 the potential to skew antiviral immune responses to thwart NK cells at the expense of potential 330 CTL activation, which suggests that NK cells represent an existential threat for many viruses. 331
12
In the course of these studies we discovered that IFN can amplify responses to aberrant 332 viral RNA products to increase HLA presentation. Specifically, we found that IAV infection of 333 A549 cells stimulated production of IFN- and IFN- in a MAVS-dependent manner, which 334 dramatically increased at later times post-infection. Conditioned medium collected from these 335 infected cells elicited modest, but significant, increases in HLA presentation on naïve epithelial 336 cells that paled in comparison to the magnitude of increase on the donor infected cells. 337
Conditioned medium collected from cells expressing IAV mvRNAs and DI RNAs similarly 338 induced modest increases in surface class I HLA proteins when incubated with naïve A549 cells. 339
We have not yet taken steps to fully characterize the composition of these culture supernatants, 340 but the available evidence points to a role for type I IFNs, and, to a lesser extent, type III IFNs. In this study we identified a viral protein, NS1, which normally prevents RIG-I-mediated 355 detection of defective viral RNAs and downstream IFN signal transduction, that restrained class I 356 HLA presentation. Indeed, NS1 not only suppressed HLA presentation on infected cells, but it 357 also had a dramatic impact on HLA expression in bystander cells; treatment of naïve A549 cells 358 with UV-inactivated culture supernatants collected from NS1 mutant virus infections elicited 359 strong class I HLA upregulation compared to controls. However, NS1 has also been shown to 360 increase transcription of the endoplasmic reticulum aminopeptidase 1 (ERAP1), which encodes a 361 13 component of the antigen presentation machinery (53). Thus, the effect of NS1 on class I HLA-362 mediated antigen presentation is not limited to the effects mediated by IFN inhibition. More 363 detailed studies of this hypervariable virulence factor will be required to fully understand the 364 impact of NS1 on innate immune responses involving NK cells. 365
The existence of aberrant IAV RNA species has been well documented, but it has been 366 less clear whether these products can benefit the virus. There is substantial evidence that 367 defective RNA products of the viral polymerase 
Culture supernatant transfer experiments 435
Media from IAV-infected, mock-infected, or transfected A549 cells was collected and 436 exposed to 1200 J/m 2 UV light in a UV cross-linker to inactivate the virus. Naive A549 cells 437 were treated with these culture supernatants for 17 h and cells were analyzed by flow cytometry 438 as described above. 439
Statistical analyses 440
Statistical significance for RT-qPCR and flow cytometry experiments were determined 441 by two-way ANOVA with Sidak's post-hoc test unless otherwise stated. For luciferase assays, 442 statistical significance was determined by a one-way ANOVA test with Tukey post-hoc test and 443 a cut-off P value of 0.05. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001, and n.s., not 444 At 17 hpi, cell supernatants were collected prior to cell fixation, and transferred to naïve A549 cells for an additional 17 h incubation prior to fixation. Donor and recipient cells were immunostained with the indicated anti-HLA antibodies to determine cell surface levels of NK cell ligands; cells were subsequently permeabilized for immunostaining of intracellular IAV proteins and analyzed by flow cytometry. Top panels show data from donor infected or mock-infected cells. Bottom panels show data from cells exposed to conditioned media. Data is presented as MFI relative to uninfected cells or conditioned media treatment from uninfected cells. Each data point represents an independent experiment. Means and ±SD are shown. * p<0.05, ** p<0.01, *** p<0.001.
